Key facts

We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. Here are some of our key facts and milestones on the way to achieving our purpose.

  • £3.9bn

    R&D investment in 2017

  • 3

    major launches in 2017 – Shingrix, a vaccine for shingles, Trelegy Ellipta for COPD and Juluca for HIV

  • £6.7bn

    new product sales in Pharmaceuticals and Vaccines in 2017

  • 13%

    Consumer Healthcare sales in 2017 from product innovations launched over the past three years

  • £30.2bn

    total turnover in 2017

  • £8.6bn

    adjusted operating profit in 2017

  • £3.4bn

    free cash flow in 2017

  • £3.9bn

    dividends paid in 2017

  • 85%

    of employees proud to work at GSK

  • £261.6m

    donated in 2017 to local communities through product donations, time and cash

  • 1st

    in Access to Medicines Index all six times since its launch in 2008

  • 100,000

    we employ around 100,000 people in over 150 countries, with more than a third of these in emerging markets

  • 11,000+

    more than 11,000 people work in R&D in our search for new medicines, vaccines and consumer healthcare products

  • 798m

    doses of vaccines sold in 2017